A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

To join this study, participants generally need to have cancer that can be measured or observed using standard medical tests. Your doctor will also check your general health and how well you can do your usual activities. This is often measured using special scores called Lansky (for younger children) or Karnofsky (for older teens and young adults).

You must have finished any previous cancer treatments at least 7 days before starting this study and have recovered from any significant side effects. Your blood tests and organ function (like kidneys and liver) need to be working well.

There are also some reasons why you might not be able to join. For example, if you have other serious health conditions, active infections, or have recently had a bone marrow or organ transplant. Females who are pregnant or breastfeeding cannot take part. Also, if you are able to have children, you would need to agree to use effective birth control during the study and for some time afterwards.

Taking part in this study would involve regular visits to the hospital for check-ups and to receive the study medication. Doctors and nurses would closely monitor your health and any side effects. You would likely have blood tests, scans, and other assessments to see how the treatment is working and to ensure your safety. The specific types of visits and tests would depend on the particular drug you are receiving and your individual situation. You would continue in the study for as long as the treatment is helping, and follow-up appointments would check on your health even after the main treatment period.